Cellectis
CLLS
#9391
Rank
โ‚น14.76 B
Marketcap
โ‚น146.55
Share price
4.79%
Change (1 day)
-54.67%
Change (1 year)

Cellectis (CLLS) Fails to deliver data

Key failure to deliver metrics for Cellectis:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Cellectis (CLLS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Cellectis (CLLS) - since 2015

Volume in USD (price x number of shares), data since 2015

Cellectis (CLLS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026โ‚น0.22 M-38.81%
2025โ‚น0.36 M-59.6%
2024โ‚น0.9 M-64.26%
2023โ‚น2.53 M-35.43%
2022โ‚น3.92 M-74.81%
2021โ‚น15.59 M-26.71%
2020โ‚น21.27 M2750.05%
2019โ‚น0.74 M-93.48%
2018โ‚น11.44 M85.32%
2017โ‚น6.17 M-25.24%
2016โ‚น8.26 M-76.95%
2015โ‚น35.83 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Regeneron Pharmaceuticals
REGN
โ‚น4.21 Mโ‚น15.54 M๐Ÿ‡บ๐Ÿ‡ธ USA
uniQure
QURE
โ‚น12.23 Mโ‚น47.82 M๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
โ‚น14.35 Mโ‚น59.52 M๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
โ‚น12.39 Mโ‚น17.27 M๐Ÿ‡บ๐Ÿ‡ธ USA